2.44
+0.055(+2.31%)
Currency In USD
| Previous Close | 2.38 |
| Open | 2.35 |
| Day High | 2.48 |
| Day Low | 2.22 |
| 52-Week High | 3.78 |
| 52-Week Low | 1.33 |
| Volume | 11,468 |
| Average Volume | 26,649 |
| Market Cap | 17.61M |
| PE | -2 |
| EPS | -1.22 |
| Moving Average 50 Days | 2.1 |
| Moving Average 200 Days | 2.68 |
| Change | 0.06 |
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
GlobeNewswire Inc.
Apr 15, 2025 1:00 PM GMT
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
GlobeNewswire Inc.
Mar 12, 2025 1:00 PM GMT
CARMEL, Ind., March 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
GlobeNewswire Inc.
Jan 21, 2025 6:45 PM GMT
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children a